Figure 6.
(A) Typical images of calcification of HASMCs induced by IL-24 and inhibition of calcification by anti-IL-24 antibody. To confirm the effect of IL-24 on HASMC calcification, the cells were incubated with the calcification medium for 15–21 days in the presence of recombinant human IL-24 (0 or 5 ng/mL) and TNF-alpha stimulation (0 or 1 ng/mL) with or without anti-IL24 antibody (0.5 μg/ml). Mineralized nodules of cells were stained with Alizarin red, and typical calcification images in HASMCs are shown. The anti-IL-24 antibody inhibited the calcification induced by IL-24 stimulation. Black bars indicate 500 micrometers. (B) Quantification of calcification of HASMCs induced by recombinant IL-24 or TNF-alpha and inhibition of the calcification by anti-IL-24 antibody by ImageJ software. The calcification areas of HASMCs stained with Alizarin red were quantified by ImageJ software. Recombinant IL-24 significantly induced HASMC calcification (P < 0.05), and the anti-IL-24 antibody significantly inhibited the calcification (P < 0.01). The calcification induced by both recombinant IL-24 and TNF-alpha was also significantly inhibited by the anti-IL-24 antibody (P < 0.05). These experiments used two cell lines of HASMCs.